Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP800761.RAjXF07_co8tjvEnUuM8jnYVVNdJ12HK2vYPERtOToqqM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP800761.RAjXF07_co8tjvEnUuM8jnYVVNdJ12HK2vYPERtOToqqM130_assertion type Assertion NP800761.RAjXF07_co8tjvEnUuM8jnYVVNdJ12HK2vYPERtOToqqM130_head.
- NP800761.RAjXF07_co8tjvEnUuM8jnYVVNdJ12HK2vYPERtOToqqM130_assertion wasGeneratedBy ECO_0000203 NP800761.RAjXF07_co8tjvEnUuM8jnYVVNdJ12HK2vYPERtOToqqM130_provenance.
- NP800761.RAjXF07_co8tjvEnUuM8jnYVVNdJ12HK2vYPERtOToqqM130_assertion wasDerivedFrom befree-20150227 NP800761.RAjXF07_co8tjvEnUuM8jnYVVNdJ12HK2vYPERtOToqqM130_provenance.
- NP800761.RAjXF07_co8tjvEnUuM8jnYVVNdJ12HK2vYPERtOToqqM130_assertion SIO_000772 19222642 NP800761.RAjXF07_co8tjvEnUuM8jnYVVNdJ12HK2vYPERtOToqqM130_provenance.
- NP800761.RAjXF07_co8tjvEnUuM8jnYVVNdJ12HK2vYPERtOToqqM130_assertion evidence source_evidence_literature NP800761.RAjXF07_co8tjvEnUuM8jnYVVNdJ12HK2vYPERtOToqqM130_provenance.
- NP800761.RAjXF07_co8tjvEnUuM8jnYVVNdJ12HK2vYPERtOToqqM130_assertion description "[Deletion of 9q34 and aberrant expression of SOCS-1 are associated with poor prognosis in CML patients with different phases of the disease under interferon therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP800761.RAjXF07_co8tjvEnUuM8jnYVVNdJ12HK2vYPERtOToqqM130_provenance.